C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway (Q28545168)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway
scientific article

    Statements

    C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway (English)
    0 references
    Ling Li
    0 references
    Qinghua Yin
    0 references
    Xi Tang
    0 references
    Lin Bai
    0 references
    Jie Zhang
    0 references
    Shenju Gou
    0 references
    Hongping Zhu
    0 references
    Jingqiu Cheng
    0 references
    Ping Fu
    0 references
    Fang Liu
    0 references
    2014
    0 references
    0 references
    9
    0 references
    11
    0 references
    e113639
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit